Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Sandoz
Sandoz
What Will Happen When Biotech Drugs Go Generic?
Forbes
Fri, 06/13/14 - 10:58 am
biotech
generics
Amgen
Roche
Biogen Idec
Eli Lilly
Bristol-Myers Squibb
Sanofi
Novartis
Sandoz
Omnitrope
Genotropin
Acura Pharma announces settlement of patent litigation with Sandoz
The Fly on the Wall
Thu, 05/22/14 - 08:28 am
Sandoz
Novartis
Acura Pharmaceuticals
patents
Aversion
Oxceta
Teva Loses Suit Against FDA Over Generic of Copaxone
Bloomberg
Thu, 05/15/14 - 07:35 am
Teva
FDA
generics
Copaxone
Mylan Labs
Novartis
Sandoz
multiple sclerosis
Drugmakers Oppose Teva Bid to Delay Copaxone Rivals
Bloomberg
Mon, 04/14/14 - 07:08 pm
Teva
Copaxone
MS
multiple sclerosis
Momenta
generics
Sandoz
Mylan
Novartis names two new leaders to growth drivers Alcon, Sandoz
Fierce Pharma
Wed, 04/9/14 - 09:43 pm
Alcon
Sandoz
Novartis
Supreme Court to decide patent dispute over multiple sclerosis treatment
Yahoo/AP
Mon, 03/31/14 - 11:00 am
Supreme Court
MS
multiple sclerosis
Copaxone
Teva Pharmaceuticals
Sandoz
Mylan
Momenta
Novartis CEO predicts generic industry fallout as quality takes center stage
Fierce Pharma Manufacturing
Fri, 03/21/14 - 08:49 am
Sandoz
Novartis
Joe Jimenez
generics
drug manufacturing
Cadence: Patent Settlement With Sandoz Increases Confidence That Ofirmev Will Have Exclusivity Through December 6, 2020
Seeking Alpha
Fri, 01/31/14 - 08:45 am
Cadence Pharmaceuticals
Sandoz
Ofirmev
Exela Pharma Sciences
Sandoz starts late-stage trial with copy of AbbVie's Humira drug
Yahoo/AP
Wed, 12/18/13 - 05:14 pm
Sandoz
generics
Humira
AbbVie
biosimilars
Novartis
Shire agrees to supply Adderall XR generic to Sandoz
Reuters
Mon, 12/2/13 - 08:40 am
Shire
generics
Sandoz
Novartis
ADHD
Adderall XR
EU To Fine J&J And Novartis Over A Pay-To-Delay Deal
Pharmalot
Mon, 11/25/13 - 09:01 am
Europe
JNJ
Novartis
pay-for-delay
generics
Sandoz
Fentanyl
pain patches
Glaxo Declines as FDA Clears Path for Advair Rivals
Bloomberg
Tue, 09/10/13 - 10:41 am
GSK
Advair
FDA
COPD
asthma
Sandoz
Actavis
Mylan
generics
Novartis tests copy of Amgen's Enbrel in late-stage trial
Reuters
Mon, 06/24/13 - 10:44 am
Amgen
Enbrel
generics
Sandoz
Novartis
chronic plaque psoriasis
Takeda, Biogen, Article One: Intellectual Property
Bloomberg
Fri, 05/31/13 - 09:07 am
Takeda
Biogen Idec
intellectual property
Novartis
Dexilant
generics
Sandoz
Tecfidera
Impax Laboratories
Novartis’s Biosimilar Rituxan Is ‘On Track,’ Sandoz Head Says
Bloomberg
Thu, 03/7/13 - 11:43 am
Rituxan
biosimilars
Novartis
Sandoz
Allergan wins round in patent fight over Lumigan
Reuters
Tue, 01/29/13 - 10:27 am
Allergan
patents
Lumigan
Teva
Sandoz
glaucoma
Novartis Drug Diovan Retains 69% of Prescriptions in U.S.
Bloomberg
Tue, 10/16/12 - 10:51 am
Novarits
Diovan
generics
Sandoz
Novartis Sandoz unit completes Fougera purchase
Yahoo/AP
Mon, 07/23/12 - 09:18 am
Sandoz
Novartis
Fougera
M&A
Alabama Court Tosses Verdict Against Sandoz
Pharmalot
Mon, 07/16/12 - 12:26 pm
Alabama
Sandoz
Novartis
Medicaid fraud
Sandoz recalls some Introvale birth control pills
Reuters
Thu, 06/7/12 - 03:20 pm
Sandoz
Novartis
birth control pill
recalls
Introvale
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
next ›
last »